Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation

Allergy. 2024 May;79(5):1361-1364. doi: 10.1111/all.16019. Epub 2024 Jan 9.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Female
  • Humans
  • Inflammation / drug therapy
  • Male
  • Psoriasis* / drug therapy
  • Psoriasis* / immunology
  • Th2 Cells* / immunology
  • Th2 Cells* / metabolism
  • Treatment Outcome

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized